The Korean journal of internal medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Comparison of the Applicability of Two Prognostic Scoring Systems In Patients with Fulminant Hepatic Failure

  • Choi, Won-Choong (Department of Internal Medicine, Sanggye-Paik Hospital, Inje University, College of Medicine) ;
  • Arnaout, Walid C. (The Center for Liver Diseases and Transplantation and The Burns and Allen Research Institute Cedars-Sinai Medical Center) ;
  • Villamil, Federico G. (The Center for Liver Diseases and Transplantation and The Burns and Allen Research Institute Cedars-Sinai Medical Center) ;
  • Demetriou, Achilles A. (The Center for Liver Diseases and Transplantation and The Burns and Allen Research Institute Cedars-Sinai Medical Center) ;
  • Vierling, John M. (The Center for Liver Diseases and Transplantation and The Burns and Allen Research Institute Cedars-Sinai Medical Center)
  • Published : 20070600
⟨ Previous Next ⟩

Abstract

Background : Distinguishing those patients with fulminant hepatic failure (FHF) and who require transplantation from those FHF patients who will survive with receiving only intensive medical care remains problematic, and this distinction is important because of the chronic shortage of donor livers. Methods : To assess the applicability of two prognostic scoring systems, referred to as the London and Clichy criteria, we compared using both systems, at the time of admission, for 43 FHF patients (15 M/28 F; age: 3716 yrs). Acetaminophen (ACM) was the etiology for 16 patients, while the remaining 27 had other etiologies. All the patients received intensive care, and 18 (8 ACM/10 non-ACM) had investigational BAL support. Results : For the ACM toxicity, neither the London nor the Clichy criteria exhibited acceptable sensitivity (71 vs 86%, respectively), specificity (78 vs 56%, respectively), a positive predictive value (71 vs 60%, respectively), a negative predictive value (78 vs 83%, respectively) or predictive accuracy (75 vs 69%, respectively) to predict patient survival without transplantation. In contrast, applying the London and Clichy criteria to the FHF patients with non-ACM etiologies showed a sensitivity of 96 vs 80%, respectively, a specificity of 100 vs 100%, respectively, a positive predictive value of 100 vs 100%,, respectively a negative predictive value of 67 vs 29%, respectively and a predictive accuracy of 96% vs 82%, respectively. Conclusions : Overall, the London criteria more accurately predicted the need for transplantation, and neither the London criteria nor the Clichy prognostic criteria accurately predicted the outcome of those patients who suffered with FHF due to ACM. BAL support may have contributed to the survival of the patients with ACM toxicity and who didn't undergo transplantation, and this survival exceeded the predictions of both prognostic systems. Additional multicenter studies should be conducted to refine these prognostic scoring systems, and this will help physicians rapidly identify those FHF patients who can survive without undergoing liver transplantation.

Keywords

Acknowledgement

This study was supported, in part, by a Glaxo Wellcome Grant from the Korean Association for the Study of Liver Disease, and the grant was awarded to Won-Choong Choi, M.D.

References

  1. Trey C, Davidson CS. The management of fulminant hepatic failure. In: Popper H, Schaffner F, eds. Progress in liver diseases. p. 282-292, New York, Grune & Stratton, 1970
  2. Bernuau J, Rueff B, Benhamou JP. Fulminant and subfulminant liver failure: definitions and causes. Semin Liver Dis 6:97-106, 1986 https://doi.org/10.1055/s-2008-1040593
  3. Gimson AE, O'Grady J, Ede RJ, Portmann B, Williams R. Late onset hepatic failure: clinical, serological and histological features. Hepatology 6:288-294, 1986 https://doi.org/10.1002/hep.1840060222
  4. Williams R. Classification, etiology, and considerations of outcome in acute liver failure. Semin Liver Dis 16:343-348, 1996 https://doi.org/10.1055/s-2007-1007247
  5. Tandon BN, Bernauau J, O'Grady J, Gupta SD, Krisch RE, Liaw YF, Okuda K, Acharya SK. Recommendations of the International Association for the Study of the Liver Subcommittee on nomenclature of acute and subacute liver failure. J Gastroenterol Hepatol 14:403-404, 1999 https://doi.org/10.1046/j.1440-1746.1999.01905.x
  6. O'Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet 342:273-275, 1993
  7. Lee WM. Acute liver failure. N Engl J Med 329:1862-1872, 1993
  8. Bismuth H, Samuel D, Castaing D, Williams R, Pereira SP. Liver transplantation in Europe for patients with acute liver failure. Semin Liver Dis 16:415-425, 1996 https://doi.org/10.1055/s-2007-1007254
  9. Vickers C, Neuberger J, Buckels J, McMaster P, Elias E. Transplantation of the liver in adults and children with fulminant hepatic failure. J Hepatol 7:143-150, 1988 https://doi.org/10.1016/S0168-8278(88)80475-6
  10. O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 97:439- 445, 1989 https://doi.org/10.1016/0016-5085(89)90081-4
  11. Riordan SM, Williams R. Use and validation of selection criteria for liver transplantation in acute liver failure. Liver Transpl 6:170-173, 2000 https://doi.org/10.1002/lt.500060221
  12. Bernuau J, Samuel D, Durand F, Saliba F, Bourliere Meal. Criteria for emergency liver transplantation in patients with acute viral hepatitis and factor V below 50% of normal. Hepatology 14:49A, 1991
  13. Bernuau J. Selection for emergency liver transplantation. J Hepatol 19:486-487, 1993
  14. Bernuau J, Goudeau A, Poynard T, Dubois F, Lesage G, Yvonnet B, Degott C, Bezeaud A, Rueff B, Benhamou JP. Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology 6:648-651, 1986 https://doi.org/10.1002/hep.1840060417
  15. Bismuth H, Samuel D, Castaing D, Adam R, Saliba F, Johann M, Azoulay D, Ducot B, Chiche L. Orthotopic liver transplantation in fulminant and subfulminant hepatitis. Ann Surg 222:109-119, 1995 https://doi.org/10.1097/00000658-199508000-00002
  16. Shakil AO, Kramer D, Mazariegos GV, Fung JJ, Rakela J. Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl 6:163-169, 2000
  17. Denninger J, Durand F, Benhamou JP. Underestimation of coagulation factor V level in frozen-thawed plasma samples from patients with acute and chronic liver disease: a prospective study. Hepatology 16:277A, 1992
  18. Watanabe FD, Shackleton CR, Cohen SM, Goldman DE, Arnaout WS, Hewitt W, Colquhoun SD, Fong TL, Vierling JM, Busuttil RW, Demetriou AA. Treatment of acetaminophen-induced fulminant hepatic failure with a bioartificial liver. Transplant Proc 29:487-488, 1997
  19. Watanabe FD, Mullon CJ, Hewitt WR, Arkadopoulos N, Kahaku E, Eguchi S, Khalili T, Arnaout W, Shackleton CR, Rozqa J, Solomon B, Demetriou AA. Clinical experience with a bioartificial liver in the treatment of severe liver failure: a phase I clinical trial. Ann Surg 225:484-491, 1997 https://doi.org/10.1097/00000658-199705000-00005
  20. Bland M. An introduction to medical statistics. 2nd ed. Oxford, Oxford University Press, 1995
  21. O'Grady J. Acute liver failure. J R Coll Physicians Lond 31:603-607, 1997
  22. Riordan SM, Williams R. Cause and prognosis in acute liver failure. Liver Transpl Surg 5:86-89, 1999 https://doi.org/10.1002/lt.500050107
  23. Riordan SM, Williams R. Fulminant hepatic failure. Clin Liver Dis 4:25-45, 2000 https://doi.org/10.1016/S1089-3261(05)70095-7
  24. Pauwels A, Mostefa-Kara N, Florent C, Levy VG. Emergency liver transplantation for acute liver failure: evaluation of London and Clichy criteria. J Hepatol 17:124-127, 1993
  25. Schiodt FV, Atillasoy E, Shakil AO, Schiff ER, Caldwell C, Kowdley KV, Stribling R, Crippin JS, Flamm S, Somberg KA, Rosen H, McCashland TM, Hay JE, Lee WM. Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transpl Surg 5:29-34, 1999 https://doi.org/10.1002/lt.500050102
  26. Campbell DA Jr, Ham JM, McCurry KR, Lucey MR, Turcotte JG, Merion RM. Liver transplant for fulminant hepatic failure. Am Surg 57:546-549, 1991
  27. Devictor D, Desplanques L, Debray D, Ozier Y, Dubousset AM, Valayer J, Houssin D, Bernard O, Huault G. Emergency liver transplantation for fulminant liver failure in infants and children. Hepatology 16:1156-1162, 1992 https://doi.org/10.1002/hep.1840160509
  28. Emond JC, Aran PP, Whitington PF, Broelsch CE, Baker AL. Liver transplantation in the management of fulminant hepatic failure. Gastroenterology 96:1583-1588, 1989 https://doi.org/10.1016/0016-5085(89)90530-1
  29. Anand AC, Nightingale P, Neuberger JM. Early indicators of prognosis in fulminant hepatic failure: an assessment of the King's criteria. J Hepatol 26:62-68, 1997 https://doi.org/10.1016/S0168-8278(97)80010-4
  30. Izumi S, Langley PG, Wendon J, Ellis AJ, Pernambuco RB, Hughes RD, Williams R. Coagulation factor V levels as a prognostic indicator in fulminant hepatic failure. Hepatology 23:1507-1511, 1996 https://doi.org/10.1002/hep.510230630
  31. Dhiman RK, Seth AK, Jain S, Chawla YK, Dilawari JB. Prognostic evaluation of early indicators in fulminant hepatic failure by multivaliative analysis. Dig Dis Sci 43:1311-1316, 1998 https://doi.org/10.1023/A:1018876328561
  32. Stevens AC, Busuttil R, Han S, Baquerizo A, Fair J, Shrestha R. An interim analysis of a phase II/III prospective randomized, multicenter, controlled trial of the Hepatassist bioartificial liver support system for the treatment of fulminant hepatic failure. Hepatology 34:299A, 2001
  33. Demetriou AA, Brown RS, Busuttil RW, Fair J, McGuire BM, Rosenthal P, Am Esch JS 2nd, Lerut J, Nyberg SL, Salizzoni M, Fagan EA, de Hemptinne B, Broelsch CE, Muraca M, Salmeron JM, Rabkin JM, Metselaar HJ, Pratt D, De La Mata M, McChesney LP, Everson GT, Lavin PT, Stevens AC, Pitkin Z, Solomon BA. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Am Surg 239:660-667, 2004